Dreavent Capital
North America, Massachusetts, United States, Cambridge
Description
Dreavent Capital is an investment firm focused on Biotech Therapeutics companies.
Investor Profile
Dreavent Capital has made 6 investments, with 0 in the past 12 months and 33% as lead.
Stage Focus
- Series A (50%)
- Series Unknown (33%)
- Series B (17%)
Country Focus
- United States (83%)
- Spain (17%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Pharmaceutical
- Clinical Trials
- Personal Health
- Precision Medicine
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.